\BOOKMARK [1][-]{section.1}{Introduction}{}% 1
\BOOKMARK [1][-]{section.2}{Methods}{}% 2
\BOOKMARK [2][-]{subsection.2.1}{Dataset}{section.2}% 3
\BOOKMARK [2][-]{subsection.2.2}{Variant\040classification\040occurrence\040probability}{section.2}% 4
\BOOKMARK [2][-]{subsection.2.3}{Integrating\040observed\040true\040positives\040and\040unobserved\040false\040negatives\040into\040a\040single,\040actionable\040conclusion}{section.2}% 5
\BOOKMARK [2][-]{subsection.2.4}{Validation\040of\040autosomal\040dominant\040estimates\040using\040NFKB1}{section.2}% 6
\BOOKMARK [2][-]{subsection.2.5}{Validation\040study\040for\040autosomal\040recessive\040CF\040using\040CFTR}{section.2}% 7
\BOOKMARK [2][-]{subsection.2.6}{Validation of SCID-specific estimates using PIDâ€“SCID genes}{section.2}% 8
\BOOKMARK [2][-]{subsection.2.7}{Protein\040network\040and\040genetic\040constraint\040interpretation}{section.2}% 9
\BOOKMARK [2][-]{subsection.2.8}{Gene\040set\040enrichment\040test}{section.2}% 10
\BOOKMARK [2][-]{subsection.2.9}{Deriving\040novel\040PID\040classifications\040by\040genetic\040PPI\040and\040clinical\040features}{section.2}% 11
\BOOKMARK [2][-]{subsection.2.10}{Probability\040of\040observing\040AlphaMissense\040pathogenicity}{section.2}% 12
\BOOKMARK [2][-]{subsection.2.11}{Probability\040model\040definitions}{section.2}% 13
\BOOKMARK [1][-]{section.3}{Results}{}% 14
\BOOKMARK [2][-]{subsection.3.1}{Occurrence\040probability\040across\040disease\040genes}{section.3}% 15
\BOOKMARK [2][-]{subsection.3.2}{Integrating\040observed\040true\040positives\040and\040unobserved\040false\040negatives\040into\040a\040single,\040actionable\040conclusion}{section.3}% 16
\BOOKMARK [2][-]{subsection.3.3}{Scenario\040one\040-\040complete\040coverage\040and\040simple\040diagnosis}{section.3}% 17
\BOOKMARK [2][-]{subsection.3.4}{Scenario\040two\040-\040incomplete\040coverage\040and\040complex\040diagnosis}{section.3}% 18
\BOOKMARK [2][-]{subsection.3.5}{Scenario\040three\040-\040currently\040impossible\040diagnosis}{section.3}% 19
\BOOKMARK [2][-]{subsection.3.6}{Posterior\040probabilities\040are\040calculated\040across\040all\040qualifying\040variants}{section.3}% 20
\BOOKMARK [2][-]{subsection.3.7}{Validation\040studies}{section.3}% 21
\BOOKMARK [2][-]{subsection.3.8}{Application\040to\040inborn\040errors\040of\040immunity}{section.3}% 22
\BOOKMARK [2][-]{subsection.3.9}{Probability\040of\040observing\040AlphaMissense\040pathogenicity}{section.3}% 23
\BOOKMARK [2][-]{subsection.3.10}{Integration\040of\040variant\040probabilities\040into\040IEI\040genetics\040data}{section.3}% 24
\BOOKMARK [1][-]{section.4}{Discussion}{}% 25
\BOOKMARK [1][-]{section.5}{Conclusion}{}% 26
\BOOKMARK [1][-]{section.6}{Supplemental}{}% 27
\BOOKMARK [2][-]{subsection.6.1}{Variant\040class\040occurrence\040probability}{section.6}% 28
\BOOKMARK [2][-]{subsection.6.2}{Integrating\040observed\040true\040positives\040and\040unobserved\040false\040negatives\040into\040a\040single,\040actionable\040conclusion}{section.6}% 29
\BOOKMARK [2][-]{subsection.6.3}{Validation\040studies}{section.6}% 30
\BOOKMARK [2][-]{subsection.6.4}{Genetic\040constraint\040in\040high-impact\040protein\040networks}{section.6}% 31
\BOOKMARK [2][-]{subsection.6.5}{Novel\040PID\040classifications\040derived\040from\040genetic\040PPI\040and\040clinical\040features}{section.6}% 32
\BOOKMARK [2][-]{subsection.6.6}{Probability\040of\040observing\040AlphaMissense\040pathogenicity}{section.6}% 33
